Bayer Baycol-related layoffs
Executive Summary
Bayer will cut pharmaceutical group by 1,250 employees following withdrawal of the cholesterol-reducing drug Baycol (cerivastatin), CFO Werner Wenning says Oct. 2. The cuts are on top of a previously announced global headcount reduction by 4,000 positions (not all of which are in pharma)
You may also be interested in...
Bayer consolidation
Bayer plans to cut pharmaceutical business operating costs by about $370 mil. in 18 months by eliminating 1,300 staff positions and closing West Haven, Conn. production facility, company says May 22. West Haven manufacturing will be transferred to plants in Europe and Shawnee, Kan. The latest layoffs bring the total number of job cuts announced since Bayer's Baycol withdrawal in August to 2,600 (1"The Pink Sheet" Oct. 8, 2001, In Brief)...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011